Orchestra BioMed (OBIO) - 2024 Q3 - Quarterly Report

Table of Contents | --- | --- | |-------|-----------------------------------------------------------------------------------| | | UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 | | | FORM 10-Q | | | | (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____________ ...